Urokinase type plasminogen activator receptor expression in colorectal neoplasms. 1998

S Suzuki, and Y Hayashi, and Y Wang, and T Nakamura, and Y Morita, and K Kawasaki, and K Ohta, and N Aoyama, and S R Kim, and H Itoh, and Y Kuroda, and W F Doe
First Division of Pathology, Kobe University School of Medicine, Kobe, Japan.

BACKGROUND The urokinase type plasminogen activator receptor (uPAR) may play a critical role in cancer invasion and metastasis. OBJECTIVE To study the involvement of uPAR in colorectal carcinogenesis. METHODS The cellular expression and localisation of uPAR were investigated in colorectal adenomas and invasive carcinomas by in situ hybridisation, immunohistochemistry, and northern and western blot analyses. RESULTS uPAR mRNA expression was found mainly in the cytoplasm of dysplastic epithelial cells of 30% of adenomas with mild (19%), moderate (21%), and severe (47%) dysplasia, and in that of carcinomatous cells of 85% of invasive carcinomas: Dukes' stages A (72%), B (93%), and C (91%). Some stromal cells in the adjacent neoplastic epithelium were faintly positive. Immunoreactivity for uPAR was detected in dysplastic epithelial cells of 14% of adenomas and in carcinomatous cells of 49% of invasive carcinomas. uPAR mRNA and protein concentrations were significantly higher in severe than in mild or moderate dysplasia (p<0.05); they were notably higher in Dukes' stage A than in severe dysplasia (p<0.05), and significantly higher in Dukes' stage B than in stage A (p<0.05), but those in stage B were not different from those in stage C or in metastatic colorectal carcinomas of the liver. CONCLUSIONS Colorectal adenoma uPAR, expressed essentially in dysplastic epithelial cells, was upregulated with increasing severity of atypia, and increased notably during the critical transition from severe dysplasic adenoma to invasive carcinoma. These findings implicate uPAR expression in the invasive and metastatic processes of colorectal cancer.

UI MeSH Term Description Entries
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D010960 Plasminogen Activators A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation. Extrinsic Plasminogen Activators,Plasminogen Activator,Uterine-Tissue Plasminogen Activator,Uterine Tissue Plasminogen Activator
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015152 Blotting, Northern Detection of RNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES. Northern Blotting,Blot, Northern,Northern Blot,Blots, Northern,Blottings, Northern,Northern Blots,Northern Blottings
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal

Related Publications

S Suzuki, and Y Hayashi, and Y Wang, and T Nakamura, and Y Morita, and K Kawasaki, and K Ohta, and N Aoyama, and S R Kim, and H Itoh, and Y Kuroda, and W F Doe
May 2000, Pathology international,
S Suzuki, and Y Hayashi, and Y Wang, and T Nakamura, and Y Morita, and K Kawasaki, and K Ohta, and N Aoyama, and S R Kim, and H Itoh, and Y Kuroda, and W F Doe
June 2005, Applied immunohistochemistry & molecular morphology : AIMM,
S Suzuki, and Y Hayashi, and Y Wang, and T Nakamura, and Y Morita, and K Kawasaki, and K Ohta, and N Aoyama, and S R Kim, and H Itoh, and Y Kuroda, and W F Doe
July 1999, The Journal of investigative dermatology,
S Suzuki, and Y Hayashi, and Y Wang, and T Nakamura, and Y Morita, and K Kawasaki, and K Ohta, and N Aoyama, and S R Kim, and H Itoh, and Y Kuroda, and W F Doe
July 2017, Oncology letters,
S Suzuki, and Y Hayashi, and Y Wang, and T Nakamura, and Y Morita, and K Kawasaki, and K Ohta, and N Aoyama, and S R Kim, and H Itoh, and Y Kuroda, and W F Doe
March 2008, Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology,
S Suzuki, and Y Hayashi, and Y Wang, and T Nakamura, and Y Morita, and K Kawasaki, and K Ohta, and N Aoyama, and S R Kim, and H Itoh, and Y Kuroda, and W F Doe
June 2000, British journal of haematology,
S Suzuki, and Y Hayashi, and Y Wang, and T Nakamura, and Y Morita, and K Kawasaki, and K Ohta, and N Aoyama, and S R Kim, and H Itoh, and Y Kuroda, and W F Doe
December 2003, Archives of otolaryngology--head & neck surgery,
S Suzuki, and Y Hayashi, and Y Wang, and T Nakamura, and Y Morita, and K Kawasaki, and K Ohta, and N Aoyama, and S R Kim, and H Itoh, and Y Kuroda, and W F Doe
May 1995, International journal of cancer,
S Suzuki, and Y Hayashi, and Y Wang, and T Nakamura, and Y Morita, and K Kawasaki, and K Ohta, and N Aoyama, and S R Kim, and H Itoh, and Y Kuroda, and W F Doe
March 2014, The Korean journal of internal medicine,
S Suzuki, and Y Hayashi, and Y Wang, and T Nakamura, and Y Morita, and K Kawasaki, and K Ohta, and N Aoyama, and S R Kim, and H Itoh, and Y Kuroda, and W F Doe
October 2003, Annals of surgical oncology,
Copied contents to your clipboard!